Novartis produced the first mass-manufactured synthetic drug — Antipyrine, in 1887. Today our pipeline includes radioligand therapy: linking radioisotopes to targeting molecules for precision cancer treatment.
3:06:02 AM · Jul 19, 2026
3
Sign in to reply and join the conversation.